Efficacy of the treatment with interferon, ribavirin and amantadine, in patients with hepatitis C non-responders or relapsers to the conventional therapy.

被引：0
|
作者：
Carmen, SE [1 ]
机构：
[1] Hosp Puerta Hierro, Madrid, Spain
来源：
HEPATOLOGY | 2002年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1701
引用
收藏
页码：588A / 588A
页数：1
相关论文
共 50 条
  • [1] Interferon alpha with ribavirin for the treatment of chronic hepatitis C in non-responders or relapsers to interferon monotherapy
    Moreno-Monteagudo, JA
    Fernandez-Bermejo, M
    Garcia-Buey, L
    Sanz, P
    Iacono, LO
    Garcia-Monzon, C
    Borque, MJ
    Moreno-Otero, R
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1998, 12 (08) : 717 - 723
  • [2] Prolonged interferon treatment after combination interferon and ribavirin therapy in patients with chronic hepatitis C: A clinical trial of interferon relapsers and non-responders
    Kao, JH
    Lai, MY
    Chen, PJ
    Cheng, YM
    Chen, DS
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2001, 100 (10) : 662 - 667
  • [3] Triple therapy (interferon, ribavirin, amantadine) for non-responders of combination therapy with interferon and ribavirin?.
    Thuluvath, PJ
    Maygers, J
    HEPATOLOGY, 2000, 32 (04) : 557A - 557A
  • [4] Induction therapy in combination with ribavirin for interferon non-responders and relapsers.
    Perrillo, RP
    Murugan, N
    Denham, C
    Totaro, R
    HEPATOLOGY, 2000, 32 (04) : 350A - 350A
  • [5] Ribavirin followed by alpha interferon retreatment in relapsers and in non-responders to alpha interferon for chronic hepatitis C
    Bellobuono, A
    Mondazzi, L
    Tempini, S
    Bellati, G
    Ideo, G
    HEPATOLOGY, 1996, 23 (01) : P99 - P99
  • [6] Combination therapy with interferon alfa-2b, ribavirin, and amantadine in chronic hepatitis C non-responders to interferon and ribavirin
    Pande, H
    Thuluvath, PJ
    Jaffer, SA
    Maygers, J
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S96 - S96
  • [7] Treatment of chronic hepatitis c with consensus interferon in relapsers and non-responders to interferon-based therapy
    Steffen, M.
    Cornberg, M.
    Buggisch, P.
    HEPATO-GASTROENTEROLOGY, 2007, 54 (80) : 2368 - 2372
  • [8] A comparison of combination therapy with interferon and ribavirin vs interferon and amantadine in interferon non-responders with chronic hepatitis C.
    Khalili, M
    Olmeda, M
    Denham, CB
    Perrillo, RP
    HEPATOLOGY, 1998, 28 (04) : 169A - 169A
  • [9] Randomized controlled trial of interferon gamma versus amantadine in combination with interferon alpha and ribavirin for hepatitis C genotype 3 non-responders and relapsers
    Abbas, Zaigham
    Raza, Sajjad
    Hamid, Saeed
    Jafri, Wasim
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2012, 62 (04) : 338 - 343
  • [10] Interferon alfa plus ribavirin in chronic hepatitis C relapsers and non-responders to previous interferon alfa course
    Salmerón, J
    Vivaldi, RM
    De la Mata, M
    Romero, M
    Moreno, JP
    Aguilar, J
    Palacios, A
    Nogueras, F
    Vignote, M
    Alcántara, R
    Suarez, E
    Andrade, R
    Rodriguez, L
    Sanchez, H
    Quintero, D
    JOURNAL OF HEPATOLOGY, 2000, 32 : 185 - 185
12345